# XORTX Therapeutics Inc. (XRTX)

Source page: https://stoqly.net/companies/xrtx

- **Ticker:** XRTX (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001729214
- **Latest annual report:** 20-F filed 2026-03-20 (https://www.sec.gov/Archives/edgar/data/1729214/000110465926032775/tmb-20251231x20f.htm)
- **Data updated:** 2026-11-09

## Key figures

- **Last close:** $0.85 on 2026-11-09 (−7.14% on the day)
- **Market cap:** $4.0M
- **EPS, trailing 12 months:** −$0.56
- **Return on equity:** −98.0%
- **Change in share count:** +64.5%
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/xrtx/figures.csv

| US$ millions | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|
| Net income | -2 | -3 | -3 |
| Diluted EPS (US$) | -1.09 | -1.15 | -0.56 |
| Operating cash flow | -7 | -4 | -3 |
| Free cash flow | -7 | — | — |
| Cash | 3 | 2 | 1 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.